Literature DB >> 11910357

Corticosteroids modulate the secretory processes of the rat intrahepatic biliary epithelium.

Domenico Alvaro1, Alessandro Gigliozzi, Luca Marucci, Gianfranco Alpini, Barbara Barbaro, Rita Monterubbianesi, Lara Minetola, Maria Grazia Mancino, Juan F Medina, Adolfo F Attili, Antonio Benedetti.   

Abstract

BACKGROUND & AIMS: We investigated the expression of glucocorticoid receptors (GcRs) in the intrahepatic biliary epithelium and the role of corticosteroids in the regulation of cholangiocyte secretion.
METHODS: GcR was studied by immunohistochemistry, reverse-transcription polymerase chain reaction, and Western blots. The effects of dexamethasone and budesonide on biliary bicarbonate excretion and H+/HCO3- transport processes were investigated in bile fistula rats, isolated intrahepatic bile duct units (IBDUs), and purified cholangiocytes.
RESULTS: GcRs were expressed by rat cholangiocytes. Although acute administration of corticosteroids showed no effect, treatment for 2 days with dexamethasone or budesonide increased (P < 0.05) biliary bicarbonate concentration and secretion, which were blocked by the specific GcR antagonist, RU-486. IBDUs isolated from rats treated with dexamethasone or budesonide showed an increased (P < 0.05) activity of the Na+/H+ exchanger (NHE1 isoform) and Cl-/HCO3- exchanger (AE2 member), which was blocked by RU-486. Protein expression of NHE1 and AE2 and messenger RNA for NH1 but not AE2 were increased (P < 0.05) in isolated cholangiocytes by dexamethasone treatment.
CONCLUSIONS: The intrahepatic biliary epithelium expresses GcR and responds to corticosteroids by increasing bicarbonate excretion in bile. This is caused by corticosteroid-induced enhanced activities and protein expression of transport processes driving bicarbonate excretion in the biliary epithelium.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11910357     DOI: 10.1053/gast.2002.32374

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  15 in total

1.  Corticosteroid treatment in biliary atresia: Tonic or toast?

Authors:  Ronald J Sokol
Journal:  Hepatology       Date:  2007-12       Impact factor: 17.425

Review 2.  Physiology of cholangiocytes.

Authors:  James H Tabibian; Anatoliy I Masyuk; Tetyana V Masyuk; Steven P O'Hara; Nicholas F LaRusso
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

Review 3.  Pathobiology of biliary epithelia.

Authors:  Angela C Cheung; Maria J Lorenzo Pisarello; Nicholas F LaRusso
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-07-15       Impact factor: 5.187

Review 4.  Cholangiocyte anion exchange and biliary bicarbonate excretion.

Authors:  Jesús-M Banales; Jesus Prieto; Juan-F Medina
Journal:  World J Gastroenterol       Date:  2006-06-14       Impact factor: 5.742

5.  Efficacy of and prognosis after steroid pulse therapy in patients with poor reduction of jaundice after laparoscopic Kasai portoenterostomy.

Authors:  Yujiro Tanaka; Chiyoe Shirota; Takahisa Tainaka; Wataru Sumida; Kazuo Oshima; Satoshi Makita; Tomoko Tanaka; Yukiko Tani; Kosuke Chiba; Hiroo Uchida
Journal:  Pediatr Surg Int       Date:  2019-08-08       Impact factor: 1.827

6.  Suppression of the HPA axis during extrahepatic biliary obstruction induces cholangiocyte proliferation in the rat.

Authors:  Matthew Quinn; Yoshiyuki Ueno; Hae Yong Pae; Li Huang; Gabriel Frampton; Cheryl Galindo; Heather Francis; Darijana Horvat; Matthew McMillin; Sharon Demorrow
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-10-06       Impact factor: 4.052

Review 7.  Biliary atresia.

Authors:  Giorgina Mieli-Vergani; Diego Vergani
Journal:  Semin Immunopathol       Date:  2009-06-17       Impact factor: 9.623

Review 8.  Nuclear receptors as therapeutic targets in cholestatic liver diseases.

Authors:  Gernot Zollner; Michael Trauner
Journal:  Br J Pharmacol       Date:  2009-01       Impact factor: 8.739

Review 9.  Bile formation and secretion.

Authors:  James L Boyer
Journal:  Compr Physiol       Date:  2013-07       Impact factor: 9.090

10.  Combination of ursodeoxycholic acid and glucocorticoids upregulates the AE2 alternate promoter in human liver cells.

Authors:  Fabián Arenas; Isabel Hervias; Miriam Uriz; Ruth Joplin; Jesús Prieto; Juan F Medina
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.